Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olfa Karoui

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Journal of Infection|June 19, 2024
Randomised, double-blind, controlled phase 1 trial of the candidate tuberculosis vaccine ChAdOx1-85A delivered by aerosol versus intramuscular routeRégine Audran, Olfa Karoui, Laura Donnet, et al.
International Archives of Allergy and Immunology|June 13, 2019
Novel Nanofluidic IgE Assay versus a Reference Method: A Real-World ComparisonSamuel Roethlisberger, Olfa Karoui, Daria Mapelli, et al.
The Lancet. Respiratory Medicine|November 25, 2015
Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trialFrançois Spertini, Régine Audran, Reza Chakour, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2018
The Candidate Blood-stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase 1 Trial in Exposed and Nonexposed VolunteersViviane Steiner-Monard, Kassim Kamaka, Olfa Karoui, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Journal of Infection|June 19, 2024
Randomised, double-blind, controlled phase 1 trial of the candidate tuberculosis vaccine ChAdOx1-85A delivered by aerosol versus intramuscular routeRégine Audran, Olfa Karoui, Laura Donnet, et al.
International Archives of Allergy and Immunology|June 13, 2019
Novel Nanofluidic IgE Assay versus a Reference Method: A Real-World ComparisonSamuel Roethlisberger, Olfa Karoui, Daria Mapelli, et al.
The Lancet. Respiratory Medicine|November 25, 2015
Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trialFrançois Spertini, Régine Audran, Reza Chakour, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2018
The Candidate Blood-stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase 1 Trial in Exposed and Nonexposed VolunteersViviane Steiner-Monard, Kassim Kamaka, Olfa Karoui, et al.
Pageof 1